NovoCure (NASDAQ: NVCR) director granted RSUs and options in 2026 award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
NovoCure Ltd director Kristin Stafford received new equity awards. She was granted 11,610 ordinary shares in the form of restricted stock units at no cash cost, increasing her direct holdings to 22,934 ordinary shares.
She also received stock options for 16,999 ordinary shares at an exercise price of $16.15 per share. According to the award terms, the restricted stock units are scheduled to vest 100% on the earlier of the first anniversary of the grant date or the day immediately preceding NovoCure's 2027 annual general meeting of shareholders. The options are scheduled to vest and become fully exercisable on the same timetable.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Stafford Kristin
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 16,999 | $0.00 | -- |
| Grant/Award | Ordinary Shares | 11,610 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 16,999 shares (Direct, null);
Ordinary Shares — 22,934 shares (Direct, null)
Footnotes (1)
- Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders. Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.
Key Figures
RSU grant: 11,610 shares
Shares held after grant: 22,934 shares
Stock options granted: 16,999 options
+3 more
6 metrics
RSU grant
11,610 shares
Restricted stock units granted June 3, 2026
Shares held after grant
22,934 shares
Direct ordinary shares following RSU grant
Stock options granted
16,999 options
Options on ordinary shares granted June 3, 2026
Option exercise price
$16.15 per share
Exercise price for 16,999 options
RSU vesting trigger
First anniversary / pre-2027 AGM
RSUs vest 100% on earlier of these dates
Option expiration
June 3, 2036
Expiration date for 16,999 stock options
Key Terms
restricted stock units, stock option, exercise price, vest, +1 more
5 terms
restricted stock units financial
"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock option financial
"Stock Option (Right to Buy)"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "16.1500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"scheduled to vest 100% on the earlier of the following dates"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What insider transactions did NovoCure (NVCR) director Kristin Stafford report?
Kristin Stafford reported equity compensation grants, not market trades. She received 11,610 ordinary shares as restricted stock units and stock options for 16,999 ordinary shares, all awarded on June 3, 2026, with no cash purchase involved.
What are the key terms of Kristin Stafford’s NovoCure stock options?
Stafford received options for 16,999 ordinary shares with a $16.15 exercise price. These options are scheduled to fully vest and become exercisable on the earlier of the first anniversary of the June 3, 2026 grant or the day before NovoCure’s 2027 annual general meeting.
When do Kristin Stafford’s NovoCure restricted stock units vest?
The 11,610 restricted stock units are scheduled to vest 100% on the earlier of two dates: the first anniversary of the June 3, 2026 grant date or the day immediately preceding NovoCure’s 2027 annual general meeting of shareholders, according to the award terms.